Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 24 studies | 26% ± 9% | |
fibroblast | 11 studies | 30% ± 8% | |
oligodendrocyte | 9 studies | 32% ± 8% | |
capillary endothelial cell | 8 studies | 21% ± 6% | |
endothelial cell of artery | 8 studies | 24% ± 8% | |
adipocyte | 6 studies | 36% ± 4% | |
vein endothelial cell | 6 studies | 28% ± 17% | |
astrocyte | 6 studies | 34% ± 16% | |
retinal bipolar neuron | 5 studies | 41% ± 20% | |
basal cell | 5 studies | 26% ± 17% | |
epithelial cell | 4 studies | 30% ± 12% | |
plasmacytoid dendritic cell | 4 studies | 24% ± 7% | |
microglial cell | 3 studies | 20% ± 5% | |
ciliated cell | 3 studies | 24% ± 5% | |
OFF-bipolar cell | 3 studies | 58% ± 7% | |
ON-bipolar cell | 3 studies | 66% ± 13% | |
rod bipolar cell | 3 studies | 38% ± 13% | |
secretory cell | 3 studies | 17% ± 2% | |
endothelial cell of vascular tree | 3 studies | 38% ± 18% | |
endothelial cell of lymphatic vessel | 3 studies | 18% ± 3% | |
macrophage | 3 studies | 24% ± 5% | |
pericyte | 3 studies | 20% ± 5% | |
renal alpha-intercalated cell | 3 studies | 24% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 99% | 1514.09 | 1435 / 1445 | 95% | 9.86 | 174 / 183 |
lung | 99% | 1634.41 | 575 / 578 | 89% | 6.56 | 1028 / 1155 |
thymus | 100% | 3634.91 | 653 / 653 | 82% | 12.87 | 494 / 605 |
pancreas | 93% | 945.82 | 306 / 328 | 84% | 5.11 | 149 / 178 |
stomach | 100% | 2085.71 | 358 / 359 | 77% | 4.83 | 221 / 286 |
skin | 100% | 2464.68 | 1804 / 1809 | 75% | 4.83 | 353 / 472 |
prostate | 98% | 1060.44 | 240 / 245 | 76% | 4.76 | 383 / 502 |
intestine | 100% | 2494.19 | 963 / 966 | 73% | 3.80 | 385 / 527 |
breast | 100% | 2300.83 | 458 / 459 | 70% | 4.73 | 781 / 1118 |
uterus | 100% | 1637.74 | 170 / 170 | 69% | 5.01 | 315 / 459 |
bladder | 95% | 1761.29 | 20 / 21 | 63% | 3.63 | 317 / 504 |
kidney | 89% | 772.35 | 79 / 89 | 63% | 4.05 | 569 / 901 |
brain | 58% | 459.28 | 1536 / 2642 | 78% | 4.43 | 550 / 705 |
ovary | 98% | 831.03 | 176 / 180 | 36% | 1.25 | 155 / 430 |
adrenal gland | 88% | 758.83 | 228 / 258 | 38% | 1.63 | 87 / 230 |
adipose | 100% | 2641.04 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 1962.20 | 798 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1097.23 | 1316 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 1108.77 | 807 / 861 | 0% | 0 | 0 / 0 |
spleen | 80% | 542.13 | 194 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 78% | 9.97 | 35 / 45 |
liver | 44% | 244.96 | 99 / 226 | 15% | 0.53 | 60 / 406 |
lymph node | 0% | 0 | 0 / 0 | 28% | 1.16 | 8 / 29 |
peripheral blood | 13% | 115.86 | 121 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 0.26 | 8 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002088 | Biological process | lens development in camera-type eye |
GO_0007601 | Biological process | visual perception |
GO_0008150 | Biological process | biological_process |
GO_0032991 | Cellular component | protein-containing complex |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0051018 | Molecular function | protein kinase A binding |
GO_0005212 | Molecular function | structural constituent of eye lens |
Gene name | CRYBG3 |
Protein name | Very large A-kinase anchor protein (vlAKAP) (Beta/gamma crystallin domain-containing protein 3) Crystallin beta-gamma domain containing 3 |
Synonyms | |
Description | FUNCTION: [Isoform vlAKAP]: Anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA). . |
Accessions | C9J659 ENST00000389622.7 [Q68DQ2-3] Q68DQ2 ENST00000495403.1 |